# Study of the Safety and Tolerability of AXA1957 in Adolescent Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)

> **NCT04073407** · NA · TERMINATED · sponsor: **Axcella Health, Inc** · enrollment: 9 (actual)

## Conditions studied

- NAFLD

## Interventions

- **DIETARY_SUPPLEMENT:** AXA1957
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04073407
- **Lead sponsor:** Axcella Health, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-07-27
- **Primary completion:** 2020-04-15
- **Final completion:** 2020-09-01
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Sponsor has determined that information it would have collected would not inform future development of a therapy with AXA 1957 for NAFLD
- **Last updated:** 2021-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04073407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04073407, "Study of the Safety and Tolerability of AXA1957 in Adolescent Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04073407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*